Logo image of NEPH

NEPHROS INC (NEPH) Stock Price, Forecast & Analysis

USA - NASDAQ:NEPH - US6406714005 - Common Stock

4.92 USD
-0.11 (-2.19%)
Last: 11/20/2025, 8:09:27 PM

NEPH Key Statistics, Chart & Performance

Key Statistics
Market Cap52.15M
Revenue(TTM)14.16M
Net Income(TTM)1.33M
Shares10.60M
Float9.41M
52 Week High5.98
52 Week Low1.39
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.13
PE37.85
Fwd PE80.39
Earnings (Next)03-04 2026-03-04/amc
IPO2004-09-21
Sector
GICS SectorIndustrials
GICS IndustryMachinery
GICS IndustryGroupCapital Goods


NEPH short term performance overview.The bars show the price performance of NEPH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

NEPH long term performance overview.The bars show the price performance of NEPH in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300

The current stock price of NEPH is 4.92 USD. In the past month the price decreased by -4.28%. In the past year, price increased by 225.83%.

NEPHROS INC / NEPH Daily stock chart

NEPH Latest News, Press Relases and Analysis

NEPH Competitors/Peers

The largest stocks on the US markets in the "Industrial Machinery & Supplies & Components" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
PH PARKER HANNIFIN CORP 28.87 103.69B
ITW ILLINOIS TOOL WORKS 23.39 70.28B
OTIS OTIS WORLDWIDE CORP 21.99 34.09B
XYL XYLEM INC 28.52 33.60B
SYM SYMBOTIC INC 364.8 32.31B
IR INGERSOLL-RAND INC 23.15 29.63B
DOV DOVER CORP 19.12 24.41B
SNA SNAP-ON INC 17.37 17.23B
FTV FORTIVE CORP 15.5 17.20B
ITT ITT INC 28.08 13.95B
RBC RBC BEARINGS INC 39.28 13.50B
GGG GRACO INC 28.26 13.20B

About NEPH

Company Profile

NEPH logo image Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

Company Info

NEPHROS INC

380 Lackawanna Pl

South Orange NEW JERSEY 07079 US

CEO: Andrew Astor

Employees: 31

NEPH Company Website

NEPH Investor Relations

Phone: 12013435202

NEPHROS INC / NEPH FAQ

What does NEPH do?

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.


What is the stock price of NEPHROS INC today?

The current stock price of NEPH is 4.92 USD. The price decreased by -2.19% in the last trading session.


What is the dividend status of NEPHROS INC?

NEPH does not pay a dividend.


What is the ChartMill rating of NEPHROS INC stock?

NEPH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the employee count for NEPH stock?

NEPHROS INC (NEPH) currently has 31 employees.


What is the market capitalization of NEPH stock?

NEPHROS INC (NEPH) has a market capitalization of 52.15M USD. This makes NEPH a Micro Cap stock.


What is the Short Interest ratio of NEPHROS INC (NEPH) stock?

The outstanding short interest for NEPHROS INC (NEPH) is 0.11% of its float.


NEPH Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to NEPH. When comparing the yearly performance of all stocks, NEPH is one of the better performing stocks in the market, outperforming 98.08% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NEPH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NEPH. While NEPH has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NEPH Financial Highlights

Over the last trailing twelve months NEPH reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 244.44% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.95%
ROA 10.84%
ROE 13.82%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%35.42%
EPS 1Y (TTM)244.44%
Revenue 1Y (TTM)-0.53%

NEPH Forecast & Estimates

8 analysts have analysed NEPH and the average price target is 5.61 USD. This implies a price increase of 14.02% is expected in the next year compared to the current price of 4.92.

For the next year, analysts expect an EPS growth of 1322977426536356900% and a revenue growth 24.58% for NEPH


Analysts
Analysts82.5
Price Target5.61 (14.02%)
EPS Next Y1322977426536356900%
Revenue Next Year24.58%

NEPH Ownership

Ownership
Inst Owners45.82%
Ins Owners10.73%
Short Float %0.11%
Short Ratio0.13